Ivermectin 1% cream

DRUG3 trials

Sponsors

Galderma R&D, Insel Gruppe AG, University Hospital Bern

Conditions

Papulopustular RosaceaRosacea

Phase 2

Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea

CompletedNCT06033352

Insel Gruppe AG, University Hospital BernRosacea

Start: 2023-09-12End: 2024-11-01Updated: 2024-12-06

Phase 3

CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

CompletedNCT01493947

Galderma R&DPapulopustular Rosacea

Start: 2012-04-30End: 2013-12-31Updated: 2015-10-28

Phase 4

Oracea Soolantra Association in Participants With Severe Rosacea

CompletedNCT03075891

Galderma R&DRosacea

Start: 2017-07-05End: 2018-02-08Updated: 2021-03-16

Related Papers

Treatment of redness in rosacea with potassium-titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial.

2026-03-04

Treatment of redness in rosacea with potassium–titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial

Figshare2026-03-04

Treatment of redness in rosacea with potassium–titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial

Figshare2026-03-04